Source: Veristat Blog

Veristat Blog Strengthening Opportunities for Growth in the European Region

With the recent changes in clinical trial regulations and the growth of clinical trials in Europe, Veristat continues to build its footprint in the European region. Veristat’s VP of Europe, Montserrat Barcélo Riera, recently spoke to Annelot Huijgen of Biotech Finances to share updates on Veristat’s growth trajectory in Europe and how

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Patrick Flanagan's photo - Chairman & CEO of Veristat

Chairman & CEO

Patrick Flanagan

CEO Approval Rating

88/100

Read more